Apotex signs MAN deal with Cygnal Technologies
Cygnal Technologies Corp. has been selected to provide a dedicated communications network connecting four Greater Toronto Area locations of Apotex Inc., the largest Canadian-owned pharmaceutical compa...
November 1, 2005
Print this page
Cygnal Technologies Corp. has been selected to provide a dedicated communications network connecting four Greater Toronto Area locations of Apotex Inc., the largest Canadian-owned pharmaceutical company.
The five-year contract includes the implementation and maintenance of Nortel equipment and Rogers fiber to create a SONET metro area network, providing Apotex with dedicated bandwidth to more tightly integrate its major sites in the GTA.
After a period of rapid expansion during which it has completed major expansions to several sites, Apotex has found that some of its facilities require additional bandwidth to take full advantage of modern technologies.
“A dedicated network will accommodate our growing need for real-time communications and information sharing among technical and research staff,” said William Shanks, Apotex Manager of Telecommunications and Network Services.
Cygnal will implement a metro area network built on Nortel’s Optera Metro 3500 platform, utilizing a combination of Apotex’s existing fiber infrastructure and Rogers Cable’s fiber network to provide connectivity between the four sites.